C. M. Boesjes, “Effectiveness of Upadacitinib in Patients with Atopic Dermatitis including those with Inadequate Response to Dupilumab and/or Baricitinib: Results from the BioDay Registry”, Acta Derm Venereol, vol. 103, p. adv00872, Feb. 2023.